A spectacular milestone has been captured in our journey of healthcare excellence! Pharoania Pharmaceuticals proudly hosted a prestigious kick-off event to launch our latest advanced therapeutic innovation, Methapharon. This landmark event, attended by our senior leadership and supported by one of Egypt’s leading orthopedic professors, marks the debut of a premium, dual-action Dexamethasone injection. By masterfully combining short-acting and long-acting formulations, Methapharon is engineered to deliver immediate and sustained relief, swiftly securing its position as a market leader in pain and inflammation care.
This launch perfectly pictures Pharoania Pharma’s pioneering role in the Egyptian pharmaceutical market and our vision to introduce highly competitive, top-tier treatments. It stands as a visual testament to our commitment to being a true partner in success for Egyptian doctors and a key supporter of health for all Egyptians.
